Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
30
31
1
2
3
4
5
6
7
8
9
11
12
13
16
17
18
19
21
23
24
25
26
27
29
30
31
1
The International Meeting for Simulation in Healthcare
2015-01-10 - 2015-01-14    
All Day
Registration is Open! Please join us on January 10-14, 2015 for our fifteenth annual IMSH at the Ernest N. Morial Convention Center in New Orleans, Louisiana. Over [...]
Finding Time for HIPAA Amid Deafening Administrative Noise
2015-01-14    
1:00 pm - 3:00 pm
January 14, 2015, Web Conference 12pm CST | 1pm EST | 11am MT | 10am PST | 9am AKST | 8am HAST Main points covered: [...]
Meaningful Use  Attestation, Audits and Appeals - A Legal Perspective
2015-01-15    
2:00 pm - 3:30 pm
Join Jim Tate, HITECH Answers  and attorney Matt R. Fisher for our first webinar event in the New Year.   Target audience for this webinar: [...]
iHT2 Health IT Summit
2015-01-20 - 2015-01-21    
All Day
iHT2 [eye-h-tee-squared]: 1. an awe-inspiring summit featuring some of the world.s best and brightest. 2. great food for thought that will leave you begging for more. 3. [...]
Chronic Care Management: How to Get Paid
2015-01-22    
1:00 pm - 2:00 pm
Under a new chronic care management program authorized by CMS and taking effect in 2015, you can bill for care that you are probably already [...]
Proper Management of Medicare/Medicaid Overpayments to Limit Risk of False Claims
2015-01-28    
1:00 pm - 3:00 pm
January 28, 2015 Web Conference 12pm CST | 1pm EST | 11am MT | 10am PST | 9AM AKST | 8AM HAST Topics Covered: Identify [...]
Events on 2015-01-10
Events on 2015-01-20
iHT2 Health IT Summit
20 Jan 15
San Diego
Events on 2015-01-22
Latest News

Cleveland Clinic study finds melanoma linked to pregnancy

Your College Path to Health Information Management

Melanoma, the deadliest form of skin cancer, is on the rise in women of child-bearing age. Those at the greatest risk, according to new Cleveland Clinic research, are women younger than 50 who are pregnant or have recently been pregnant.

Researchers from Cleveland Clinic’s Dermatology & Plastic Surgery Institute discovered that women diagnosed with malignant melanoma during their pregnancy or within one year of giving birth were 5.1-times as likely to die, 6.9-times as likely to experience metastasis, and 9.2-times more likely to have a recurrence.

The researchers believe pregnancy hormones may fuel the cancer.

The case-control study, published online today in of the Journal of the American Academy of Dermatology, used a large clinical database of electronic medical records to collect detailed data of melanomas developing in 462 women aged 49 years or younger.

“We saw significant, worse prognoses and outcomes for women with a pregnancy-associated melanoma, compared to a control group of non-pregnant women,” said Brian Gastman, M.D., a plastic surgeon, director of melanoma surgery at Cleveland Clinic, and primary investigator on the study.

“The rate of metastasis, recurrence and death in our findings were astounding — as the rates were measurably higher in women who were diagnosed with melanoma while pregnant, or within one year after delivery,” Dr. Gastman added.

The study is a stark reminder of the importance of skin cancer prevention. The rates of melanoma have been rising for at least 30 years, and rates in the United States have doubled from 1982 to 2011.

According to the authors, women below 50, particularly those who are pregnant and at higher risk of developing melanoma, should be extra-vigilant in monitoring changing skin lesions and maintaining diligent dermatological follow up.

Ultraviolet radiation from the sun and artificial sources is the most preventable risk factor for all forms of skin cancer, including melanoma.

To protect the skin from harmful UV rays, the American Academy of Dermatology recommends seeking shade, wearing protective clothing and using a broad-spectrum, water-resistant sunscreen with an SPF of 30 or higher.

The AAD also advises the public to steer clear of tanning beds, a source of artificial UV radiation that increases the risk of melanoma, especially in women 45 and younger.